NCT06583512View on ClinicalTrials.gov

Treatment Duration of IPA

Active, not recruitingOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

August 31, 2025

Study Completion Date

August 31, 2026

Conditions
Invasive AspergillosisAntifungal Therapy
Trial Locations (1)

100044

Peking University People's Hospital, Beijing

All Listed Sponsors
lead

Peking University People's Hospital

OTHER

NCT06583512 - Treatment Duration of IPA | Biotech Hunter | Biotech Hunter